Stratos Wealth Partners LTD. Has $415,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Stratos Wealth Partners LTD. lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,367 shares of the company’s stock after selling 1,863 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in GE HealthCare Technologies were worth $415,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. First Command Advisory Services Inc. boosted its stake in GE HealthCare Technologies by 36,900.0% in the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after purchasing an additional 369 shares in the last quarter. Pin Oak Investment Advisors Inc. acquired a new position in GE HealthCare Technologies during the 2nd quarter worth about $25,000. Householder Group Estate & Retirement Specialist LLC bought a new stake in GE HealthCare Technologies during the 3rd quarter worth about $26,000. Legacy Financial Group LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Finally, OFI Invest Asset Management bought a new position in shares of GE HealthCare Technologies in the third quarter worth about $26,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 2.2 %

Shares of NASDAQ:GEHC opened at $86.28 on Friday. The company’s 50-day moving average price is $88.21 and its two-hundred day moving average price is $77.29. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. The stock has a market capitalization of $39.37 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 3.07 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. GE HealthCare Technologies’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.31 earnings per share. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on GEHC shares. Citigroup raised their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. HSBC started coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 target price for the company. Mizuho raised their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Finally, Argus raised their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $95.08.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.